Clearside Biomedical Inc’s recently made public that its CHIEF MEDICAL OFFICER Chong Ngai Hang Victor acquired Company’s shares for reported $48000.0 on Mar 20 ’24. In the deal valued at $1.60 per share,30,000 shares were bought. As a result of this transaction, Chong Ngai Hang Victor now holds 30,000 shares worth roughly $39000.0.
Then, WHITMORE BRADFORD T bought 444,444 shares, generating $599,999 in total proceeds. Upon buying the shares at $1.35, the 10% Owner now owns 4,495,034 shares.
Before that, LASEZKAY GEORGE M sold 18,000 shares. Clearside Biomedical Inc shares valued at $22,860 were divested by the CEO at a price of $1.27 per share. As a result of the transaction, LASEZKAY GEORGE M now holds 466,577 shares, worth roughly $0.61 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. ROTH Capital began covering CLSD with “Buy” recommendation on May 13, 2020. Needham revised its rating on August 09, 2019. It rated CLSD as “a Hold” which previously was an “a Buy”.
Price Performance Review of CLSD
On Friday, Clearside Biomedical Inc [NASDAQ:CLSD] saw its stock fall -2.26% to $1.30. Over the last five days, the stock has lost -15.03%. Clearside Biomedical Inc shares have risen nearly 11.11% since the year began. Nevertheless, the stocks have fallen -3.70% over the past one year. While a 52-week high of $2.12 was reached on 03/12/24, a 52-week low of $0.65 was recorded on 01/26/24. SMA at 50 days reached $1.4591, while 200 days put it at $1.1402. A total of 0.52 million shares were traded, compared to the trading of 0.19 million shares in the previous session.
Levels Of Support And Resistance For CLSD Stock
The 24-hour chart illustrates a support level at 1.2546, which if violated will result in even more drops to 1.2092. On the upside, there is a resistance level at 1.3708. A further resistance level may holdings at 1.4416. The Relative Strength Index (RSI) on the 14-day chart is 38.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.2174, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.72%. Stochastics %K at 19.20% indicates the stock is a buying.
How much short interest is there in Clearside Biomedical Inc?
A steep rise in short interest was recorded in Clearside Biomedical Inc stocks on Mar 15, 2024, growing by 0.18 million shares to a total of 0.34 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.16 million shares. There was a rise of 52.36%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 0.48% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.59.
